Safety and Biomarker Study of EPI-589 in Subjects With ALS

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Drug: EPI-589
Sponsor:   Edison Pharmaceuticals Inc
Recruiting - verified July 2016